Abstract
This study evaluates the Delaware Cancer Registry’s 2010-2014 colon cancer data using Cancer Program Practice Profile Reports (CP3R) quality of care measures developed by the American College of Surgeons Commission on Cancer. The CP3R measures assess: 1) the number of regional lymph nodes removed and pathologically examined for resected colon cancer (12RLN); and 2) the provision of adjuvant chemotherapy for Stage III patients (ACT). Research was conducted in the Delaware Health Information Network and with hospital cancer registries for cases missing values for provision of chemotherapy. Percentages of cases meeting the standard of care were calculated after stratification by sex and race.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
